Status epileptikus, hiperglisemi, ciddi metabolik asidoz ve hepatotoksisite ile prezente olan izoniazid intoksikasyonu

İzoniazid (izonikotinik asit hidrazid [INH]) bir antimikrobiyal olup tüberküloz profilaksi ve tedavisinde ilk seçenek ajan olarak kullanılmaktadır. Tüberkülozun yayılımını kontrol altına almada İzoniazid’in artan kullanımından dolayı klinisyen ilacın potansiyel fatal etkilerinin farkında olmalıdır. Akut yüksek doz antikonvulzanlara cevap vermeyen tekrarlayıcı nöbetler, yüksek anyon gapli metabolik asidoz ve koma ile seyreden triad ile karakterizedir ve potansiyel fatal olabilir. Izoniazid yüksek doz alımı acil servise bu triadla gelen her hastada düşünülmelidir. Biz de burada multipl, jeneralize, tonikklonik nöbet, ciddi metabolik asidoz ve hiperglisemi ile prezente olan INH toksikasyonu vakasını sunduk.

Isoniazid intoxication presenting as status epilepticus, hyperglycemia, severe metabolic acidosis and hepatotoxicity

Isoniazid (isonicotinic acid hydrazide [INH]) is an antimicrobial that has been used as a firstline agent for prophylaxis and treatment of tuberculosis. Since isoniazid is increasingly being used to control the spread of tuberculosis, physicians must be aware of its potentially fatal effects. An acute overdose is potentially fatal and is characterized by the clinical triad of repetitive seizures unresponsive to the usual anticonvulsants, metabolic acidosis with a high anion gap and coma. The diagnosis of INH overdose should be considered in any patient who presents to emergency medical services with the triad. We report a patient presenting with multiple generalized tonic clonic convulsions with severe metabolic acidosis and hyperglycemia as a manifestation of INH toxicity

___

  • Mechem CC, Toxicity, Isoniazid. E Medicine Specialties-Emer- gency Medicine-Toxicology. Updated: Mar 21, 2009.
  • Romero JA, Kuczler FJ. Isoniazid overdose: recognition and man- agement. Am Fam Physician 1998;57(4):749-52.
  • Gokhale YA, Vaidya MS, Mehta AD, Rathod NN. Isoniazid toxic- ity presenting as status epilepticus and severe metabolic acidosis. J Assoc Physicians India. 2009;57:70-1.
  • Shannon MW, Lovejoy FH Jr. Isoniazid. In: Haddad LM, Win- chester JF, eds. Clinical management of poisoning and drug over- dose. 2d ed. Philadelphia: Saunders, 1990:970-5.
  • Mandell GL, Sande MA. Antimicrobial agents, drugs used in che- motherapy of tuberculosis and leprosy In: Goodman Gilman A, Goodman LS, Rall TW, et al. The Pharmacological Basis of Thera- peutics. 8th ed, New York. Mc Millan 1991.
  • Alvarez FG, Guntupalli KK. Isoniazid overdose: four case reports and review of the literature. Intensive Care Med 1995;21:641-4.
  • Yarbrough BE, Wood JP. Isoniazid overdose treated with high- dose pyridoxine. Ann Emerg Med 1983;12:303-5.
Journal of Emergency Medicine Case Reports-Cover
  • Başlangıç: 2010
  • Yayıncı: Alpay Azap